3.2 %HIV incidence among non-Ivorian female sex workers in Côte d'Ivoire was 3.2%.
Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988
Gold tier: mechanically validated evidence, with its primary source.
709 evidence items · page 1 / 29
3.2 %HIV incidence among non-Ivorian female sex workers in Côte d'Ivoire was 3.2%.
Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988
6.7 %Among the 313 HIV antibodies carriers in Ivory Coast from January to December 1987, the frequency of HIV1 infection was 6.7%.
Côte d'IvoireHIV1observed 1987published 1989PubMedOpenAlexdocument of 10 observations
50 %Cryptococcal meningitis has a mortality rate of over 50% at 10 weeks in patients with AIDS in sub-Saharan Africa.
Côte d'Ivoireméningite cryptococciquepublished 2025IJID regionseurope_pmcdocument of 11 observations
21.7 %Bacteraemia was detected in 21.7% of febrile people in Côte d'Ivoire.
Côte d'Ivoirebacteraemiapublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations
62 patientsWe studied 62 patients (44 men, 18 women).
Côte d'IvoireVIH/sidaobserved 1999–2006published 2010Le Mali medicaleurope_pmcdocument of 17 observations
1 sensitivityDetectable HBV-DNA at baseline had sensitivity of 1.00 and specificity of 0.80 for predicting HBsAg seroclearance.
Côte d'Ivoirehépatite Bpublished 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156
58 %Among hospitalized HIV-positive adults in West Africa, 58% were women.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
14.3 %Among HIV-infected pregnant women exposed to efavirenz (EFV) during the first trimester, the proportion of abortion was 14.3%.
Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
2.5 %Cryptococcal meningitis represented 2.5% of hospitalizations.
Côte d'Ivoireméningite cryptococciqueobserved 2008 to 2011published 2017Journal de mycologie medicaleeurope_pmcdocument of 11 observations
25 %Of the patients with detectable viral loads at month 24, 25% still did not harbor resistant virus.
Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations
0.5 %At 10 years, scale-back strategies increase projected HIV transmissions by 0.5% to 19.4%.
Côte d'IvoireVIH/sidaobserved 10 yearspublished 2017Annals of internal medicineeurope_pmcdocument of 6 observations
97.15 %Plasmodium falciparum accounted for 97.15% of identified Plasmodium species among 2246 positive blood smears.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
Extrapulmonary or disseminated tuberculosis at ART initiation was associated with TB-IRIS.
Côte d'IvoireTB-IRIS · tuberculosepublished 2024Open forum infectious diseaseseurope_pmcdocument of 9 observations
33.3 %Among 66 HBsAg-positive patients, 33.3% were inactive HBV carriers.
Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
2.42 %In Bouaké, symptomatic cases prevalence recorded in August 2016 was 2.42% (66/2725).
Côte d'Ivoirepaludismeobserved August 2016HAL · Unilimdocument of 122 observations
35.3 %Among the 17 patients remaining in care, six (35.3%) had an undetectable viral load.
Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642
0 casesNo case of HIV seroconversion was reported 6 months after exposure among AEB victims.
Côte d'IvoireVIH/sidaobserved 6 month after exposurepublished 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations
47.3 %At month 36, 47.3% of the patients were lost to follow-up.
Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations
15 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 15.0% for those with no/primary education level, 16.7% for those with secondary-1st cycle education, and 9.5% for those with secondary-2nd cycle or university education in the COVADOCY study conducted in 2025.
Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations
435,000 deathsIn 2017, an estimated 435,000 malaria-related deaths were reported globally.
Côte d'Ivoirepaludismeobserved 2017HAL · Unilimdocument of 122 observations
3 %HIV incidence among female sex workers aged 24 years or less in Côte d'Ivoire was 3.0%.
Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988
169 cells/mm³In ART-treated patients, the CD4 count increased by 169 cells/mm³ after 24 months on ART for dually seropositive patients.
Côte d'IvoireVIH/sidaobserved 24 monthspublished 2013PloS oneeurope_pmcdocument of 14 observations
280 cells/mm3Patients in the deferred group who started ART had a lower median CD4 count (280 cells/mm3) at baseline.
Côte d'IvoireVIH/sidapublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 8 observations
13.4 %HBsAg prevalence was 13.4% among 491 adult HIV patients in Abidjan.
Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
50 %50% of the patients (14 out of 28) were antiretroviral therapy experienced.
Côte d'IvoireVIH/sidapublished 2025IJID regionseurope_pmcdocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.